💨 Abstract

Eli Lilly is raising the price of the weight-loss drug Mounjaro (tirzepatide) in the UK by 170% starting September 1. The highest dose will increase from £122 to £330 per month. This price hike, aligned with global pricing strategies, is part of a broader effort to balance costs across different regions. The change does not affect NHS patients but will impact those purchasing privately.

Courtesy: Katie Boyden